• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种方便的方法,用于测量接受大剂量静脉内给予抗坏血酸的患者的血液抗坏血酸浓度。

A convenient method for measuring blood ascorbate concentrations in patients receiving high-dose intravenous ascorbate.

机构信息

Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, KS 66160, USA.

出版信息

J Am Coll Nutr. 2013;32(3):187-93. doi: 10.1080/07315724.2013.791167.

DOI:10.1080/07315724.2013.791167
PMID:23885992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3725640/
Abstract

OBJECTIVE

A simple method of using fingerstick blood glucose (FSBG) monitors to estimate blood ascorbate values after high-dose intravenous (IV) ascorbate infusion is evaluated as a substitution for high-performance liquid chromatography (HPLC) measurement.

METHODS

In 33 participants, readings from FSBG monitors were taken before and after IV ascorbate infusions at various time points, with the postinfusion FSBG readings subtracted from the baseline glucose readings. The results of the subtractions (AAFSBG) were correlated with ascorbate concentrations detected by HPLC (AAHPLC).

RESULTS

A linear regression was found between ascorbate concentrations detected by the fingerstick method (AAFSBG) and by HPLC (AAHPLC). The linear correlations were identical in healthy subjects, diabetic subjects, and cancer patients. Analysis of variance obtained an AAFSBG/AAHPLC ratio of 0.90, with a 90% confidence interval of (0.69, 1.20). The corrections of AAFSBG improved similarity to AAHPLC but did not significantly differ from the uncorrected values.

CONCLUSION

The FSBG method can be used as an approximate estimation of high blood ascorbate concentration after IV ascorbate (>50 mg/dL, or 2.8 mM) without correction. However, this measurement is not accurate in detecting lower or baseline blood ascorbate. It is also important to highlight that in regard to glucose monitoring, FSBG readings will be erroneously elevated following IV ascorbate use and insulin should not be administered to patients based on these readings.

摘要

目的

评估一种使用指尖血糖(FSBG)监测仪估计高剂量静脉(IV)给予抗坏血酸后血液抗坏血酸值的简单方法,作为高效液相色谱(HPLC)测量的替代方法。

方法

在 33 名参与者中,在 IV 抗坏血酸输注的各个时间点之前和之后,从 FSBG 监测仪读取读数,将输注后的 FSBG 读数从基线葡萄糖读数中减去。减法的结果(AAFSBG)与 HPLC 检测到的抗坏血酸浓度(AAHPLC)相关。

结果

在指尖法(AAFSBG)和 HPLC (AAHPLC)检测到的抗坏血酸浓度之间发现了线性回归。线性相关性在健康受试者、糖尿病患者和癌症患者中是相同的。方差分析得出 AAFSBG/AAHPLC 比值为 0.90,90%置信区间为(0.69,1.20)。AAFSBG 的校正提高了与 AAHPLC 的相似性,但与未校正值没有显著差异。

结论

在没有校正的情况下,FSBG 法可用于 IV 抗坏血酸(>50mg/dL,或 2.8mM)后血液中高抗坏血酸浓度的近似估计。然而,这种测量方法在检测较低或基线血液抗坏血酸时并不准确。还需要强调的是,在葡萄糖监测方面,IV 抗坏血酸使用后 FSBG 读数会错误升高,不应根据这些读数给患者注射胰岛素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e98/3725640/e90e56398bfe/nihms469641f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e98/3725640/8aece653bc9a/nihms469641f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e98/3725640/e90e56398bfe/nihms469641f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e98/3725640/8aece653bc9a/nihms469641f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e98/3725640/e90e56398bfe/nihms469641f2.jpg

相似文献

1
A convenient method for measuring blood ascorbate concentrations in patients receiving high-dose intravenous ascorbate.一种方便的方法,用于测量接受大剂量静脉内给予抗坏血酸的患者的血液抗坏血酸浓度。
J Am Coll Nutr. 2013;32(3):187-93. doi: 10.1080/07315724.2013.791167.
2
Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study.危重症非心胸外科患者胰岛素输注时的最佳血糖监测间隔:一项初步研究。
Acta Biomed. 2021 Feb 25;92(1):e2021036. doi: 10.23750/abm.v92i1.9083.
3
Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate.血细胞比容、麦芽糖和抗坏血酸盐对家用及医院血糖仪总分析误差的影响评估。
J Diabetes Sci Technol. 2010 Nov 1;4(6):1479-94. doi: 10.1177/193229681000400624.
4
Role of plasma ascorbate in diabetic microangiopathy.血浆抗坏血酸在糖尿病微血管病变中的作用。
Bangladesh Med Res Counc Bull. 1989 Dec;15(2):47-59.
5
Disturbed handling of ascorbic acid in diabetic patients with and without microangiopathy during high dose ascorbate supplementation.在高剂量补充抗坏血酸期间,伴有和不伴有微血管病变的糖尿病患者体内抗坏血酸处理紊乱。
Diabetologia. 1991 Mar;34(3):171-5. doi: 10.1007/BF00418271.
6
Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.静脉注射维生素C的临床经验:癌症患者不同炎症和疾病状态下血液中可达到的水平
J Transl Med. 2013 Aug 15;11:191. doi: 10.1186/1479-5876-11-191.
7
Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma.血浆中超高生理水平抗坏血酸的直接分光光度测定。
Redox Biol. 2016 Aug;8:298-304. doi: 10.1016/j.redox.2016.02.004. Epub 2016 Feb 13.
8
Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients.长期、低剂量静脉注射维生素C会导致血液透析患者血浆草酸钙过饱和。
Am J Kidney Dis. 2005 Mar;45(3):540-9. doi: 10.1053/j.ajkd.2004.10.025.
9
Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.使用富含抗坏血酸盐的透析液减轻维持性血液透析患者的氧化应激。
Ren Fail. 2005;27(2):213-9.
10
Vitamin C in mouse and human red blood cells: an HPLC assay.维生素 C 在小鼠和人红细胞中的含量:高效液相色谱法测定。
Anal Biochem. 2012 Jul 15;426(2):109-17. doi: 10.1016/j.ab.2012.04.014. Epub 2012 Apr 20.

引用本文的文献

1
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study.静脉注射维生素 C 的药代动力学评价:一项经典的药代动力学研究。
Clin Pharmacokinet. 2022 Sep;61(9):1237-1249. doi: 10.1007/s40262-022-01142-1. Epub 2022 Jun 25.
2
Therapeutic Efficacy of Pharmacological Ascorbate on Braf Inhibitor Resistant Melanoma Cells In Vitro and In Vivo.药理学抗坏血酸对体外和体内 BRAF 抑制剂耐药黑素瘤细胞的治疗效果。
Cells. 2022 Apr 5;11(7):1229. doi: 10.3390/cells11071229.
3
Impact of High-Dose Intravenous Vitamin C for Treatment of Sepsis on Point-of-Care Blood Glucose Readings.大剂量静脉注射维生素 C 治疗脓毒症对即时血糖读数的影响。
J Diabetes Sci Technol. 2021 Mar;15(2):309-316. doi: 10.1177/1932296819889638. Epub 2019 Nov 25.
4
Intravenous Vitamin C for Cancer Therapy - Identifying the Current Gaps in Our Knowledge.静脉注射维生素C用于癌症治疗——识别我们现有知识中的差距
Front Physiol. 2018 Aug 23;9:1182. doi: 10.3389/fphys.2018.01182. eCollection 2018.
5
Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer.癌症患者静脉注射维生素C临床经验的回顾性评估
Integr Cancer Ther. 2018 Sep;17(3):912-920. doi: 10.1177/1534735418775809. Epub 2018 May 17.
6
High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study.大剂量静脉内给予抗坏血酸抑制胰腺癌生长和转移:机制和 I/IIa 期研究。
Sci Rep. 2017 Dec 7;7(1):17188. doi: 10.1038/s41598-017-17568-8.
7
Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma.血浆中超高生理水平抗坏血酸的直接分光光度测定。
Redox Biol. 2016 Aug;8:298-304. doi: 10.1016/j.redox.2016.02.004. Epub 2016 Feb 13.
8
High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial.高剂量静脉注射维生素C联合细胞毒性化疗用于晚期癌症患者:一项I-II期临床试验。
PLoS One. 2015 Apr 7;10(4):e0120228. doi: 10.1371/journal.pone.0120228. eCollection 2015.

本文引用的文献

1
Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies.可用于补充和替代医学临床研究的前列腺成像方式。
Urol Clin North Am. 2011 Aug;38(3):343-57. doi: 10.1016/j.ucl.2011.04.003.
2
Glucose concentration determination based on silica sol-gel encapsulated glucose oxidase optical biosensor arrays.基于硅胶溶胶-凝胶封装葡萄糖氧化酶光学生物传感器阵列的葡萄糖浓度测定。
Talanta. 2010 Nov 15;83(1):61-5. doi: 10.1016/j.talanta.2010.08.039.
3
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.维生素 C:补充和替代医学从业者的静脉内使用及不良反应。
PLoS One. 2010 Jul 7;5(7):e11414. doi: 10.1371/journal.pone.0011414.
4
Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs.癌症的抗坏血酸和草药提取物催化疗法。
Evid Based Complement Alternat Med. 2010 Jun;7(2):203-12. doi: 10.1093/ecam/nem159. Epub 2007 Dec 26.
5
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.药理学剂量的抗坏血酸盐可作为一种促氧化剂,并减少小鼠体内侵袭性肿瘤异种移植物的生长。
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11105-9. doi: 10.1073/pnas.0804226105. Epub 2008 Aug 4.
6
Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.静脉注射维生素C用于晚期恶性肿瘤的I期临床试验。
Ann Oncol. 2008 Nov;19(11):1969-74. doi: 10.1093/annonc/mdn377. Epub 2008 Jun 9.
7
Amperometric glucose sensor based on catalytic reduction of dissolved oxygen at soluble carbon nanofiber.基于可溶性碳纳米纤维上溶解氧催化还原的安培型葡萄糖传感器。
Biosens Bioelectron. 2007 Nov 30;23(4):479-84. doi: 10.1016/j.bios.2007.06.009. Epub 2007 Jul 20.
8
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.药理学浓度的抗坏血酸盐在体内细胞外液中选择性地产生抗坏血酸自由基和过氧化氢。
Proc Natl Acad Sci U S A. 2007 May 22;104(21):8749-54. doi: 10.1073/pnas.0702854104. Epub 2007 May 14.
9
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.药理浓度的抗坏血酸可选择性杀死癌细胞:作为一种前药将过氧化氢输送到组织的作用。
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9. doi: 10.1073/pnas.0506390102. Epub 2005 Sep 12.
10
Vitamin C: from popular food supplement to specific drug.维生素C:从大众食品补充剂到特定药物。
Forum Nutr. 2003;56:42-5.